Timetable
Thursday, March 30, 2006
|
Two Parallel Halls |
14:00 – 14:45 |
Drug
Development |
Ocular Blood Flow |
14:45 – 15:30 |
Allergy |
15:30 – 16:00 |
Coffee break, exhibition
and poster viewing |
16:00 – 16:45 |
European Drug Development |
Macular Edema |
16:45 – 17:30 |
Ocular Microbiology |
Friday, March 31, 2006
|
Two Parallel Halls |
08:00 – 09:00 |
Free papers:
Inflammation and External Diseases |
Course: Challenging Cases in Corneal
Disorders |
09:00 – 09:45 |
High Throughput Screening of Neuroprotective
Therapies |
Ocular Toxicology |
09:45 – 10:30 |
NPDR / PDR / Neuroprotection |
Optimizing Glaucoma Management -
Merck |
10:30 – 11:00 |
Coffee break, exhibition
and poster viewing |
11:00 – 11:45 |
Ocular Toxicology of Topical Agents |
Neovascular AMD Treatment -
Pfizer |
11:45 – 12:30 |
Antioxidants |
Retisert: Intravitreal Implant -
Bausch & Lomb |
12:30 – 14:00 |
Lunch break, exhibition
and poster viewing |
14:00 – 14:45 |
From Basic Science to Clinical Practice |
Ranibizumab in neovascular AMD
|
14:45 – 15:30 |
Exudative AMD |
Free papers: Glaucoma |
15:30 – 16:00 |
Coffee break, exhibition
and poster viewing |
16:00 – 16:45 |
Exudative
AMD (continued) |
Novel Mechanisms for Pharmacological
Inhibition of Neuronal Death |
16:45 – 17:30 |
In Vitro Approaches
to Ocular Diseases & Drug
Discovery |
Saturday, April 1, 2006
|
Two Parallel Halls |
08:00 – 09:00 |
Course: Challenging Cases in Uveal
Inflammation |
Course: Challenging Cases in Retinal
Diseases |
09:00 – 09:45 |
New PDT and Combination Therapy for
CNV / AMD |
New Treatments in Dry Eye |
09:45 – 10:30 |
Vitreolytics / PVR |
Therapeutic
Modalities Against Ocular Refractory Diseases - Senju |
10:30 – 11:00 |
Coffee break, exhibition
and poster viewing |
11:00 – 12:30 |
Ocular Inflammatory Diseases |
Verteporfin’s
Future Role in AMD Therapy -
Novartis |
12:30 – 14:00 |
Lunch Break, exhibition
and poster viewing |
14:00 – 14:45 |
Improving IOP Control |
Free Papers:
Dry Eye and Antibiotic Preparations |
14:45 – 15:30 |
Common Glaucoma Debates |
15:30 – 16:00 |
Coffee break, exhibition
and poster viewing |
16:00 – 16:45 |
Drug Delivery to the Posterior
Segment of the Eyes |
Imaging Technologies as End Points |
16:45 – 17:30 |
Ocular Angiogenesis
Inhibition – Pre-Clinical
Studies |
Sunday, April 2, 2006
|
Two Parallel Halls |
08:00 – 09:00 |
Course: Challenging Cases in Glaucoma |
Course: Challenging Cases in External
Eye Diseases |
09:00 – 09:45 |
Dry AMD |
Drug Development and Drug Delivery
|
09:45 – 10:30 |
Free papers: Retina |
Clinical
Trials in Dry Eye |
10:30 – 11:00 |
Coffee break, exhibition
and poster viewing |
11:00 – 12:20 |
Free papers: Retina (continu) |
|
For full names of scientific sessions please visit: http://www.kenes.com/isopt2006/sci_main.asp
|
